Skip to main content

ResMed| income statement

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

ResMed| reported revenue of $5.65 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), up 9.9% from fiscal 2025. Net income was $1.52 billion and diluted earnings per share $10.43.

From ResMed|'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

ResMed| income statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Revenue$920.7M$1.09B$1.24B$1.37B$1.51B$1.55B$1.68B$1.84B$2.07B$2.34B$2.61B$2.96B$3.20B$3.58B$4.22B$4.69B$5.15B$5.65B$5.73B
Revenue growth—+18.6%+13.8%+10.1%+10.7%+2.7%+8.0%+9.5%+12.4%+13.2%+11.4%+13.4%+8.1%+11.9%+18.0%+10.9%+9.8%+9.9%—
Net interest income———————————−$39.36M−$23.63M−$22.31M−$47.38M−$45.71M$4.11M$49.91M—
Cost of revenue$366.9M$436.9M$501.8M$547.8M$573.8M$565.2M$667.5M$772.2M$865.0M$1.01B$1.11B$1.24B$1.36B$1.55B$1.87B$2.03B$2.09B$2.20B$2.23B
Gross profit$553.8M$655.5M$741.3M$820.7M$940.7M$989.8M$1.01B$1.07B$1.20B$1.33B$1.49B$1.72B$1.84B$2.02B$2.36B$2.66B$3.05B$3.45B$3.50B
Gross margin60.1%60.0%59.6%60.0%62.1%63.7%60.2%58.0%58.1%57.0%57.3%58.1%57.5%56.6%55.8%56.7%59.4%61.1%61.1%
Research and development$63.06M$75.20M$92.01M$109.7M$120.1M$118.2M$114.9M$118.7M$144.5M$155.1M$180.7M$201.9M$225.3M$253.6M$287.6M$307.5M$331.3M$378.3M$393.8M
Selling, general and administrative$289.9M$328.9M$372.2M$402.6M$430.8M$450.4M$478.6M$488.1M$554.0M$600.4M$645.0M$676.7M$670.4M$737.5M$874.0M$917.1M$993.0M$1.12B$1.18B
Operating expenses$363.5M$415.1M$474.4M$526.3M$585.8M$584.7M$602.2M$637.5M$775.9M$793.1M$914.8M$908.1M$935.4M$1.02B$1.22B$1.34B$1.37B$1.57B$1.61B
Operating income$190.3M$240.4M$266.9M$294.4M$354.8M$405.1M$409.2M$429.0M$425.8M$541.8M$579.3M$809.7M$903.7M$1.00B$1.13B$1.32B$1.69B$1.89B$1.89B
Operating margin20.7%22.0%21.5%21.5%23.4%26.1%24.4%23.3%20.6%23.2%22.2%27.4%28.3%28.0%26.8%28.2%32.7%33.4%33.0%
Interest expense—$2.67M$1.76M$4.79M$6.39M$6.13M$5.78M$11.21M$28.24M$28.36M$36.16M$40.38M$23.99M——————
Other income and expense$11.37M$20.21M$36.78M$37.54M$30.30M$25.99M$26.68M$10.61M−$7.05M−$20.52M−$60.42M−$76.57M−$20.02M−$39.80M−$30.21M−$55.09M−$7.80M$32.70M$118.6M
Income before tax$201.7M$260.6M$303.7M$331.9M$385.1M$431.1M$435.9M$439.6M$418.7M$521.3M$518.8M$733.1M$883.7M$960.5M$1.10B$1.26B$1.68B$1.92B$2.01B
Income tax expense$55.24M$70.50M$76.72M$77.09M$77.99M$85.81M$83.03M$87.16M$76.46M$205.7M$114.3M$111.4M$409.2M$181.0M$204.1M$243.8M$276.8M$396.1M$418.6M
Effective tax rate27.4%27.1%25.3%23.2%20.2%19.9%19.0%19.8%18.3%39.5%22.0%15.2%46.3%18.8%18.5%19.3%16.5%20.6%20.8%
Net income$146.4M$190.1M$227.0M$254.8M$307.1M$345.3M$352.9M$352.4M$342.3M$315.6M$404.6M$621.7M$474.5M$779.4M$897.6M$1.02B$1.40B$1.52B$1.59B
Net margin15.9%17.4%18.3%18.6%20.3%22.2%21.0%19.2%16.6%13.5%15.5%21.0%14.8%21.8%21.3%21.8%27.2%26.9%27.8%
EPS · diluted$0.95$1.23$1.44$1.71$2.10$2.39$2.47$2.49$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51$10.43$10.98
Diluted weighted average shares154M155M157M149M146M144M143M142M142M144M144M146M146M147M147M148M147M146M145M
Basic weighted average shares151M151M152M146M143M141M140M140M141M143M143M144M145M146M147M147M147M146M145M
EBITDA$244.3M$301.9M$337.5M$380.3M$433.1M$478.5M$482.3M$515.8M$538.0M$661.8M$730.1M$964.5M$1.06B$1.16B$1.30B$1.50B$1.88B$2.09B$2.09B
EBITDA margin26.5%27.6%27.2%27.8%28.6%30.8%28.7%28.1%26.0%28.3%28.0%32.6%33.2%32.4%30.7%31.9%36.6%36.9%36.4%
Depreciation & amortization$53.96M$61.56M$70.62M$85.86M$78.28M$73.45M$73.06M$86.85M$112.2M$120.0M$150.8M$154.8M$156.8M$159.6M$165.2M$176.9M$198.5M$201.3M$195.4M
Stock-based compensation$25.52M$29.73M$30.81M$30.59M$38.16M$43.46M$47.85M$46.41M$45.92M$48.41M$52.07M$57.56M$63.93M$65.26M$71.14M$80.18M$91.66M$104.3M$112.7M
Dividends per share————$0.68$1.00$1.12$1.20$1.32$1.40$1.48$1.56$1.56$1.68$1.76$1.92$2.12$2.40$2.46

Quarterly

ResMed| income statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$1.16B$1.20B$1.22B$1.22B$1.28B$1.29B$1.35B$1.34B$1.42B$1.43B$1.46B$1.41B
Net interest income−$13.80M−$11.03M−$5.92M−$1.66M−$775.0K$793.0K$5.76M$8.79M$7.95M$12.29M$20.89M—
Cost of revenue$515.9M$504.2M$507.7M$507.3M$530.8M$525.3M$527.9M$517.9M$544.1M$540.4M$602.4M$544.2M
Gross profit$646.9M$692.8M$715.5M$717.2M$751.3M$766.4M$820.1M$817.7M$878.7M$891.0M$861.2M$870.6M
Gross margin55.6%57.9%58.5%58.6%58.6%59.3%60.8%61.2%61.8%62.2%58.8%61.5%
Research and development$73.88M$77.07M$80.86M$79.52M$81.37M$83.94M$86.44M$89.48M$90.97M$94.27M$105.7M$102.9M
Selling, general and administrative$222.2M$229.9M$242.2M$239.0M$241.6M$245.3M$265.1M$259.2M$278.4M$285.7M$296.3M$314.7M
Operating expenses$371.8M$318.2M$334.3M$329.9M$334.0M$340.1M$365.5M$371.1M$387.1M$391.2M$412.5M$417.6M
Operating income$275.1M$374.6M$381.2M$387.3M$417.2M$426.3M$454.5M$446.5M$491.7M$499.8M$448.7M$453.0M
Operating margin23.7%31.3%31.2%31.6%32.5%33.0%33.7%33.4%34.6%34.9%30.7%32.0%
Interest expense———————$7.12M———$4.81M
Other income and expense−$15.64M$837.0K−$23.48M−$3.81M$1.08M−$8.57M$3.51M$256.0K$4.49M$2.50M$25.45M$86.17M
Income before tax$259.5M$375.4M$357.7M$383.5M$418.3M$417.7M$458.1M$446.8M$496.1M$502.3M$474.2M$539.2M
Income tax expense$50.65M$74.93M$65.50M$72.14M$73.70M$52.65M$78.35M$98.26M$103.6M$103.6M$90.73M$120.7M
Effective tax rate19.5%20.0%18.3%18.8%17.6%12.6%17.1%22.0%20.9%20.6%19.1%22.4%
Net income$208.8M$300.5M$292.2M$311.4M$344.6M$365.0M$379.7M$348.5M$392.6M$398.7M$383.4M$418.4M
Net margin18.0%25.1%23.9%25.4%26.9%28.3%28.2%26.1%27.6%27.9%26.2%29.6%
EPS · diluted$1.42$2.04$1.98$2.11$2.34$2.48$2.58$2.37$2.68$2.74$2.64$2.92
Diluted weighted average shares148M147M148M148M147M147M147M147M146M146M145M143M
Basic weighted average shares147M147M147M147M147M147M146M146M146M145M145M143M
EBITDA$319.9M$418.1M$424.9M$432.0M$463.7M$469.9M$518.2M$494.2M$541.5M$558.8M$493.5M$494.7M
EBITDA margin27.5%34.9%34.7%35.3%36.2%36.4%38.4%37.0%38.1%39.0%33.7%35.0%
Depreciation & amortization$44.78M$43.47M$43.68M$44.73M$46.44M$43.67M$63.63M$47.70M$49.88M$58.98M$44.78M$41.74M
Stock-based compensation$19.84M$20.44M$21.39M$20.16M$22.63M$24.12M$24.75M$21.16M$28.94M$26.79M$27.46M$29.48M
Dividends per share$0.48$0.48$0.48$0.53$0.53$0.53$0.53$0.60$0.60$0.60$0.60$0.66

The main figures as JSON and plain text. See data and methodology.

RMD in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.